To manage the complex but mutually beneficial network of politicians and merchants the City of Venice established and maintained a host of innovative judicial and regulatory structures.
By doing so reliable and trustworthy venues for exchange and functional methods of conflict resolution between all different classes, countries, cultures, religions and empires were established.
The area around Rialto bridge was Venice’s main market, acting as a centre of information as well as banking and financing services. Today we would call this a place or platform of collaborative networking.
Finding mutually beneficial concepts for compromises between the interests of all parties involved was a challenge then and is still a challenge now. Mastering this challenge by professional negotiations is key to success for everybody.
Ulrich is an experienced negotiator with strong marketing background. His main strengths are exploring and understanding the interests and needs of the negotiation partners, finding win-win solutions agreeable to all parties involved, focusing on project specific priorities, structuring complex processes and communicating understandably.
Over 3 decades in the Pharmaceutical industry he gained experience in the fields of Strategic Planning, Sales, Marketing and Business Development & Licensing within Schering and Bayer. As VP Negotiations Ulrich was responsible for the negotiation of Term Sheets, Contracts, Contract Amendments and Manufacturing & Supply Agreements.
Ulrich has a degree in Economics, worked in the UK (Brighton) and in the US (New York) and lives in Germany (Berlin).
During 2021/22 I was supporting the Danish company Cirqle Biomedical in partnering their project OUI for on-demand non-hormonal contraception. In July 2022 Cirqle Biomedical and Organon signed a Research Collaboration and Licensing Agreement. I wish both Cirqle Biomedical and Organon every success in the remaining process of developing this project and hope that women around the world will soon have a new option for save and reliable contraception without hormones. For further details please see the joint press release.
